國立虎尾科技大學 |

IgG4-Related Sclerosing Cholangitis

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	IgG4-Related Sclerosing Cholangitis/ edited by Terumi Kamisawa, Myung-Hwan Kim.
其他作者:	Kamisawa, Terumi.
面頁冊數:	VIII, 142 p. 54 illus., 34 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Internal medicine. -
電子資源:	https://doi.org/10.1007/978-981-10-4548-6
ISBN:	9789811045486

IgG4-Related Sclerosing Cholangitis
IgG4-Related Sclerosing Cholangitis[electronic resource] /edited by Terumi Kamisawa, Myung-Hwan Kim. - 1st ed. 2019. - VIII, 142 p. 54 illus., 34 illus. in color.online resource.

O verview including classification of sclerosing cholangitis -- Epidemiology -- Pathophysiology -- Pathology -- Clinical features -- Serology -- Diagnostic criteria -- Imaging -- 1) US and CT -- 2) MRI with MRCP -- 3) ERCP -- 4) EUS and IDUS -- Differential diagnosis from primarysclerosing cholangitis -- Differential diagnosis from cholangiocarcinoma -- Tissue acquisition for histologic diagnosis -- Other organ involvements including autoimmune pancreatitis -- Treatment -- 1) Steroids -- 2) Immunomodulatory drugs -- 3) Rituximab -- Prognosis -- IgG4-related sclerosing cholangitis in America -- IgG4-related sclerosing cholangitis in Europe -- IgG4-related disease.

This book aims to raise awareness of IgG4-related sclerosing cholangitis among practicing physicians and to equip readers with a sound understanding of the principles of diagnosis and treatment. Clinical, serological, and histopathological features are clearly described and imaging appearances on all relevant modalities are illustrated, covering the bile duct and other involved organs. Differential diagnosis from other diseases, including primary sclerosing cholangitis and cholangiocarcinoma, is precisely explained. Information is then presented on all significant current and emerging therapeutic strategies, including steroids, immunosuppressive drugs, and rituximab. Finally, attention is drawn to significant prognostic features. While IgG4-related sclerosing cholangitis is now a widely acknowledged condition, most practitioners are still liable to misdiagnose it owing to a lack of familiarity with its presenting features. This book should help to rectify the situation and will be an asset for all who may encounter the disease in clinical practice.

ISBN: 9789811045486

Standard No.: 10.1007/978-981-10-4548-6doiSubjects--Topical Terms:

644638
Internal medicine.

LC Class. No.: RC1-1245

Dewey Class. No.: 616

IgG4-Related Sclerosing Cholangitis
LDR:03051nam a22003975i 4500 001 1007234
003 DE-He213
005 20200705115133.0
007 cr nn 008mamaa
008 210106s2019 si | s |||| 0|eng d
020 $a 9789811045486 $9 978-981-10-4548-6
024 7 $a 10.1007/978-981-10-4548-6 $2 doi
035 $a 978-981-10-4548-6
050 4 $a RC1-1245
072 7 $a MJ $2 bicssc
072 7 $a MED045000 $2 bisacsh
072 7 $a MJ $2 thema
082 0 4 $a 616 $2 23
245 1 0 $a IgG4-Related Sclerosing Cholangitis $h [electronic resource] / $c edited by Terumi Kamisawa, Myung-Hwan Kim.
250 $a 1st ed. 2019.
264 1 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2019.
300 $a VIII, 142 p. 54 illus., 34 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a O verview including classification of sclerosing cholangitis -- Epidemiology -- Pathophysiology -- Pathology -- Clinical features -- Serology -- Diagnostic criteria -- Imaging -- 1) US and CT -- 2) MRI with MRCP -- 3) ERCP -- 4) EUS and IDUS -- Differential diagnosis from primarysclerosing cholangitis -- Differential diagnosis from cholangiocarcinoma -- Tissue acquisition for histologic diagnosis -- Other organ involvements including autoimmune pancreatitis -- Treatment -- 1) Steroids -- 2) Immunomodulatory drugs -- 3) Rituximab -- Prognosis -- IgG4-related sclerosing cholangitis in America -- IgG4-related sclerosing cholangitis in Europe -- IgG4-related disease.
520 $a This book aims to raise awareness of IgG4-related sclerosing cholangitis among practicing physicians and to equip readers with a sound understanding of the principles of diagnosis and treatment. Clinical, serological, and histopathological features are clearly described and imaging appearances on all relevant modalities are illustrated, covering the bile duct and other involved organs. Differential diagnosis from other diseases, including primary sclerosing cholangitis and cholangiocarcinoma, is precisely explained. Information is then presented on all significant current and emerging therapeutic strategies, including steroids, immunosuppressive drugs, and rituximab. Finally, attention is drawn to significant prognostic features. While IgG4-related sclerosing cholangitis is now a widely acknowledged condition, most practitioners are still liable to misdiagnose it owing to a lack of familiarity with its presenting features. This book should help to rectify the situation and will be an asset for all who may encounter the disease in clinical practice.
650 0 $a Internal medicine. $3 644638
650 1 4 $a Internal Medicine. $3 668583
700 1 $a Kamisawa, Terumi. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1064688
700 1 $a Kim, Myung-Hwan. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1300970
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811045479
776 0 8 $i Printed edition: $z 9789811045493
776 0 8 $i Printed edition: $z 9789811338397
856 4 0 $u https://doi.org/10.1007/978-981-10-4548-6
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)